Insider Buy/Sell Details for the Biotechnology Industry — June 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1527)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$535.01
Total Value
$42.80K
Shares Held After
49,453
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$533.79
Total Value
$256.22K
Shares Held After
49,533
% of Holdings
1.0%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Bumpus Namandje — Director
Shares
3,963
Price
$3.18
Total Value
$12.60K
Shares Held After
127,632
% of Holdings
3.0%
Xencor Inc (XNCR)
Feigal Ellen — Director
Shares
6,843
Price
$13.06
Total Value
$89.37K
Shares Held After
12,340
% of Holdings
35.7%
GYRE THERAPEUTICS, INC. (GYRE)
Ye Weiguo — Chief Operating Officer
Shares
3,000
Price
$6.35
Total Value
$19.05K
Shares Held After
700,000
% of Holdings
0.4%
Nkarta, Inc. (NKTX)
HASTINGS PAUL J — Director
Shares
1,776
Price
$2.71
Total Value
$4.81K
Shares Held After
390,247
% of Holdings
0.5%
Vericel Corp (VCEL)
Halpin Michael — Chief Operating Officer
Shares
10,000
Price
$40.24
Total Value
$402.40K
Shares Held After
16,248
% of Holdings
38.1%
Vericel Corp (VCEL)
Flynn Sean C. — Chief Legal Officer
Shares
15,000
Price
$40.21
Total Value
$603.15K
Shares Held After
1,647
% of Holdings
90.1%
ARDELYX, INC. (ARDX)
Williams Laura A — Chief Patient Officer
Shares
81,898
Price
$5.99
Total Value
$490.49K
Shares Held After
378,195
% of Holdings
17.8%
Immunovant, Inc. (IMVT)
Van Tuyl Christopher — Chief Legal Officer
Shares
2,634
Price
$35.39
Total Value
$93.22K
Shares Held After
180,597
% of Holdings
1.4%
Cardiff Oncology, Inc. (CRDF)
PACE GARY W — Director
Shares
30,000
Price
$1.22
Total Value
$36.60K
Shares Held After
1,356,376
% of Holdings
2.2%
Cardiff Oncology, Inc. (CRDF)
Mohindru Mani — Director
Shares
24,703
Price
$1.21
Total Value
$29.89K
Shares Held After
24,703
% of Holdings
100.0%
IMMUCELL CORP /DE/ (ICCC)
te Boekhorst Paul Francis Olivier — Director
Shares
8,000
Price
$9.49
Total Value
$75.96K
Shares Held After
17,785
% of Holdings
45.0%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
37,015
Price
$50.00
Total Value
$1.85M
Shares Held After
521,795
% of Holdings
6.6%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
4,656
Price
$50.00
Total Value
$232.80K
Shares Held After
558,810
% of Holdings
0.8%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
800
Price
$0.96
Total Value
$768.00
Shares Held After
300,566
% of Holdings
0.3%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
96
Price
$147.11
Total Value
$14.12K
Shares Held After
15,000
% of Holdings
0.6%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
1,199
Price
$146.24
Total Value
$175.35K
Shares Held After
15,096
% of Holdings
7.4%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
4,861
Price
$145.43
Total Value
$706.96K
Shares Held After
16,295
% of Holdings
23.0%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
3,748
Price
$144.66
Total Value
$542.19K
Shares Held After
21,156
% of Holdings
15.0%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
96
Price
$143.90
Total Value
$13.81K
Shares Held After
24,904
% of Holdings
0.4%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
1,000
Price
$52.50
Total Value
$52.50K
Shares Held After
135,215
% of Holdings
0.7%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
1,000
Price
$52.50
Total Value
$52.50K
Shares Held After
135,215
% of Holdings
0.7%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
22,236
Price
$52.50
Total Value
$1.17M
Shares Held After
474,703
% of Holdings
4.5%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
225
Price
$52.51
Total Value
$11.81K
Shares Held After
496,939
% of Holdings
0.0%
Vaxcyte, Inc. (PCVX)
GUGGENHIME ANDREW — PRESIDENT AND CFO
Shares
10,000
Price
$53.00
Total Value
$530.00K
Shares Held After
104,395
% of Holdings
8.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
400
Price
$551.74
Total Value
$220.70K
Shares Held After
45,172
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
496
Price
$548.91
Total Value
$272.26K
Shares Held After
45,572
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
881
Price
$547.65
Total Value
$482.48K
Shares Held After
46,068
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
157
Price
$546.15
Total Value
$85.74K
Shares Held After
46,949
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
480
Price
$544.26
Total Value
$261.25K
Shares Held After
47,106
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
160
Price
$541.95
Total Value
$86.71K
Shares Held After
47,586
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
950
Price
$541.25
Total Value
$514.19K
Shares Held After
47,746
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
798
Price
$540.25
Total Value
$431.12K
Shares Held After
48,696
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,305
Price
$539.42
Total Value
$703.94K
Shares Held After
49,494
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
958
Price
$538.03
Total Value
$515.43K
Shares Held After
50,799
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,715
Price
$537.04
Total Value
$921.03K
Shares Held After
51,757
% of Holdings
3.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
12,902
Price
$90.38
Total Value
$1.17M
Shares Held After
662,042
% of Holdings
1.9%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
92,169
Price
$90.38
Total Value
$8.33M
Shares Held After
3,807,660
% of Holdings
2.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
11,741
Price
$89.98
Total Value
$1.06M
Shares Held After
0
% of Holdings
100.0%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
27,695
Price
$0.35
Total Value
$9.69K
Shares Held After
303,719
% of Holdings
8.4%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
389,216
Price
$0.35
Total Value
$136.23K
Shares Held After
4,268,448
% of Holdings
8.4%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
309
Price
$79.25
Total Value
$24.49K
Shares Held After
105,272
% of Holdings
0.3%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
1,703
Price
$78.50
Total Value
$133.69K
Shares Held After
105,581
% of Holdings
1.6%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
1,850
Price
$79.24
Total Value
$146.59K
Shares Held After
105,272
% of Holdings
1.7%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
6,600
Price
$78.50
Total Value
$518.10K
Shares Held After
107,122
% of Holdings
5.8%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
1,238
Price
$44.75
Total Value
$55.40K
Shares Held After
51,000
% of Holdings
2.4%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
3,401
Price
$43.86
Total Value
$149.18K
Shares Held After
52,238
% of Holdings
6.1%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
1,379
Price
$42.78
Total Value
$59.00K
Shares Held After
55,639
% of Holdings
2.4%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
1,133
Price
$44.74
Total Value
$50.69K
Shares Held After
25,000
% of Holdings
4.3%
Showing 201–250 of 1527 transactions (page 5 of 31)